Biomerica (BMRA) EBITDA Margin Growth (3y) (2013 - 2026)
Biomerica (BMRA) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 244.00 |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 1,710.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1,710.00 |
| Nov 30, 2025 | -106.00 |
| Aug 31, 2025 | 4,544.00 |
| May 31, 2025 | -17,568.00 |
| Feb 28, 2025 | -10,673.00 |
| Nov 30, 2024 | -3,639.00 |
| Aug 31, 2024 | 4,635.00 |
| May 31, 2024 | 2,648.00 |
| Feb 29, 2024 | -13,699.00 |
| Nov 30, 2023 | 2,217.00 |
| Aug 31, 2023 | 9,414.00 |
| May 31, 2023 | -13,539.00 |
| Feb 28, 2023 | -7,087.00 |
| Nov 30, 2022 | -8,174.00 |
| Aug 31, 2022 | -8,379.00 |
| May 31, 2022 | 3,247.00 |
| Feb 28, 2022 | 5,468.00 |
| Nov 30, 2021 | 807.00 |
| Aug 31, 2021 | -8,633.00 |
| May 31, 2021 | -10,642.00 |